share_log

博腾股份(300363.SZ):服务的终端药物涉及适应症较为广泛

Boteng Co., Ltd. (300363.SZ): The terminal drug of the service involves a wide range of indications

Gelonghui Finance ·  Dec 13, 2023 02:45

Glonghui, December 13|Some investors asked Boteng Co., Ltd. (300363.SZ) on the investor interactive platform, “Does the company's service outsourcing include cardiovascular, cerebrovascular, Alzheimer's disease, diabetes, and high blood pressure?” The company replied that the terminal drugs served by the company cover a wide range of indications, and the above fields are covered in the company's history or current service projects.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment